CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: Such an increase may be involved in the decrease reported in CXCL12, the proteolytic target of CD26 [15], which could be relevant in the low cell adhesion observed in co-cultures with CD34+ CML cells.